TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›NHI
NHI logo

NHI

NATIONAL HEALTH INVESTORS INC

Next earnings Aug 4, 2026 · consensus $0.88 EPS, $111M rev

Hold
$77.49
▼ -0.14%
$77.49▲ +14.73%
over 1Y
L $67.09H $90.00
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.1%
1W+1.4%
1M+9.0%
3M-6.8%
YTD+2.0%
1Y+14.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B-
Valuation
Undervalued
Filings
Flagged
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 12 analysts
Buy

Quality triple-net senior-housing REIT with CPI-linked rent escalators, but trading near fair value with a stretched payout and rising leverage.

Revenue $80.1M · FY2025

The read

Middling fundamentals offset by an attractive price (~48% below fair value) — worth a look on the value angle.

NHI is a self-managed healthcare REIT with 189 Real Estate Investment properties across 32 states (110 SHOs, 65 SNFs, 1 hospital) leased to 31 tenants on 10–15 year triple-net leases with CPI-linked escalators, plus a smaller SHOP segment of 26 properties (3,009 units) operated via third-party managers under RIDEA. The triple-net structure pushes opex risk to tenants and the CPI escalators provide modest organic growth, while the demographic tailwind from an aging population underpins long-term demand for both need-driven (ALF/SLC) and discretionary (ILF/EFC) communities. FY2025 results show the business is executing: revenue rose 47.1% to $80.1M (boosted by SHOP consolidation, since SHOP resident-fee revenue runs through the top line while triple-net rent does not), operating cash flow grew 13.9% to $237M, and equity is up 11.3% YoY.

The quality, however, is partly offset by capital intensity and a stretched payout. Capex jumped 86.2% to $294M — well above $237M of operating cash flow — meaning the company is funding growth and a $170M dividend (up 8.4%) with external capital; share count rose 5.9% and cash fell 19.2% to just $19.6M. Diluted EPS actually slipped 3.5% to $3.02 despite the revenue surge, so dividends paid ($170M) exceed GAAP net income attributable to common ($142M), a payout that only works because REIT distributions are measured against FFO, not EPS. Leverage at 0.83x liabilities/equity is reasonable for a REIT, but $1.26B of liabilities against $19.6M cash leaves no buffer if rates stay higher for longer or if a major tenant — the filing notes 31 tenants across the triple-net book — runs into operator stress.

Is NHI a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~90d expiry
  • Long 100 shares @ ~77.49
  • Short call 81 @ ~3.00 est
debit $7,449max +$651max −$7,448BE 74.49

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$0.00$35.8M$48.8M$54.4M$80.1M
Gross profit—————
Operating income—————
Net income$112M$66.4M$136M$138M$142M
Diluted EPS$2.44$1.48$3.13$3.13$3.02
Net margin—185.5%277.9%253.6%177.6%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)8.45
Earnings yield3.8%
FCF yield-1.5%

Quality & risk

ROIC (est.)4.5%
Free cash flow-$57.5M
Total debt$1.13B
Net cash-$1.11B
Piotroski F-Score4/7

Capital returns

Buyback yield0.0%
Dividend yield (est.)4.5%
Shareholder yield4.5%
Shares Δ YoY+5.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Agreement terminated2026-07-01
  2. 8-K Officer / director change2026-07-01
  3. 8-K Other event2026-06-01

    Item 8.01 other event disclosure; routine update with no material financial impact

  4. 8-K Shareholder vote2026-05-29

    Annual meeting vote results disclosed (Item 5.07); routine governance outcome

  5. 8-K Reg FD disclosure2026-05-04

    Q1 2026 results filed; SHOP segment and triple-net portfolio operating normally

  6. 8-K Reg FD disclosure2026-05-04

    Q1 2026 results filed; SHOP segment and triple-net portfolio operating normally

  7. 10-Q Quarterly report2026-05-04

    Q1 2026 results filed; SHOP segment and triple-net portfolio operating normally

  8. 8-K/A Amended 8-K2026-04-22

    Amendment to prior 8-K providing updated/supplemental information

  9. DEF 14A Proxy statement2026-04-03

    2026 proxy filed: director slate, exec comp and auditor ratification

Recent filings

all on EDGAR ↗
3Period ending 2026-07-012026-07-02open ↗8-KPeriod ending 2026-07-012026-07-01open ↗8-KPeriod ending 2026-07-012026-07-01open ↗4Period ending 2026-06-152026-06-15open ↗4Period ending 2026-06-052026-06-09open ↗4Period ending 2026-06-052026-06-05open ↗8-KPeriod ending 2026-05-262026-06-01open ↗8-KPeriod ending 2026-05-272026-05-29open ↗4Period ending 2026-05-052026-05-07open ↗4Period ending 2026-05-052026-05-07open ↗4Period ending 2026-05-052026-05-07open ↗8-KPeriod ending 2026-05-042026-05-04open ↗

Quality score

B-
ValueGrowthProfitHealthMom.
ValueF
GrowthB+
ProfitabilityA
Financial healthA-
MomentumC-
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$114.76

Undervalued +48% vs price

cheapfair valueexpensive

Modified Graham: EPS $3.02 × (8.5 + 1.5 × 22.0% growth) × 1.05 quality = 38.0× multiple. An estimate, not a price target.

66.5352-week88.94
Revenue
$80.1M
+47.1% YoY
Net margin
177.6%
ROE
9.3%
P/E
25.7

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$80.1M+47.1%
Net income$142M+3.0%
Operating income$150M+45.9%
Diluted EPS$3.02-3.5%
Cash & equivalents$19.6M-19.2%
Total assets$2.80B+7.0%
Total liabilities$1.26B+2.3%
Stockholders' equity$1.52B+11.3%
Op.: 187.7%L/E: 0.83x

Frequently asked

Is NATIONAL HEALTH INVESTORS INC (NHI) a buy?
NHI currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Quality triple-net senior-housing REIT with CPI-linked rent escalators, but trading near fair value with a stretched payout and rising leverage.
What is NHI's fair value?
A Modified-Graham model based on NHI's SEC fundamentals estimates a fair value of about $114.76. It is an estimate from reported earnings, not a price target.
Is NHI overvalued or undervalued?
Against a Modified-Graham fair-value estimate, NHI currently appears undervalued relative to its SEC-grounded earnings power.
What is NATIONAL HEALTH INVESTORS INC's quality score?
NHI scores 68.66511089179467/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000877860, latest 10-Q filed 2026-05-04) · EODHD · Proprietary analysis · as of 6/25/2026, 1:21:55 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:21 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 2 open-market buys · 0 sales

2026-06-15
MCCABE ROBERT A JR
Director
Buy890.00 @ $71.65$63.8K
2026-06-05
Jobe James R
Director
Gift225.00
2026-06-05
Mendelsohn D. Eric
CEO and President
Buy1.50K @ $68.84$103K
2026-05-05
Spaid John L
CFO/EVP Finance
Tax314.00 @ $73.09$23.0K
2026-05-05
Mendelsohn D. Eric
CEO and President
Tax394.00 @ $73.09$28.8K
2026-05-05
Travis David L
SVP/Chief Accounting Officer
Tax282.00 @ $73.09$20.6K
2026-03-03
Donohue Lilly
Director
Award1.27K
2026-03-03
COLDEN TRACY M J
Director
Award1.27K

Dividends

Quarterly
Yield (TTM)
4.7%
Annual / share
$3.68
Last ex-date
2026-06-30
Last amount
$0.92
ex 2026-06-30paid 2026-08-07$0.92
ex 2026-03-31paid 2026-05-01$0.92
ex 2025-12-31paid 2026-01-30$0.92
ex 2025-09-30paid 2025-10-31$0.92
ex 2025-06-30paid 2025-08-01$0.90
ex 2025-03-31paid 2025-05-02$0.90

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-04Miss -4.9% est▼ -1.87%8-K ↗
2026-02-26Miss -1.9% est▼ -5.23%8-K ↗
2025-11-06Miss -8.3% est▲ +3.07%8-K ↗
2025-08-06Beat +4.3% est▲ +6.70%8-K ↗
2025-05-05—▲ +1.20%8-K ↗
2025-02-25—▲ +3.93%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

1 buy · 1 member · last 180d

+$8.00K net boughtlast trade 171d ago
$8.00K bought$0.00 sold
2026-02-13Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2022-10-12Virginia FoxxSell$50.0K–$100KPTR ↗
2022-07-05Virginia FoxxBuy$15.0K–$50.0KPTR ↗
2022-02-04Virginia FoxxSell$50.0K–$100KPTR ↗
2021-12-03Virginia FoxxBuy$1.00K–$15.0KPTR ↗
2021-09-03Virginia FoxxBuy$1.00K–$15.0KPTR ↗
2021-09-03Virginia FoxxBuy$1.00K–$15.0KPTR ↗
2021-06-03Virginia FoxxBuy$15.0K–$50.0KPTR ↗
2021-06-03Virginia FoxxBuy$15.0K–$50.0KPTR ↗
2021-05-05Virginia FoxxBuy$50.0K–$100KPTR ↗
2020-04-16Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2019-04-15Nicholas Van TaylorSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
NHC Completes Acquisition of Thirty-Five NHI FacilitiesBullish
finance.yahoo.com· 2026-07-01
SHO vs. NHI: Which Stock Is the Better Value Option?Bullish
finance.yahoo.com· 2026-06-26
Honeywell Aerospace To Join S&P 500, S&P 100Bullish
nasdaq.com· 2026-06-24
Honeywell Aerospace Set to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600Bullish
finance.yahoo.com· 2026-06-23
SHO or NHI: Which Is the Better Value Stock Right Now?Bullish
finance.yahoo.com· 2026-06-10
A Look At National Health Investors (NHI) Valuation After Recent Share Price PullbackBullish
finance.yahoo.com· 2026-06-01

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score69 vs 67
Revenue growth47.1% vs 7.5%
Net margin177.6% vs 10.0%
Return on equity9.3% vs 12.0%
P/E25.7 vs 26.2